Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 57460-41-0, Cordanum, 1-(4-(3-(tert-butylamino)-2-hydroxypropoxy)phenyl)-3-cyclohexylurea, Talinolol [inn], 38649-73-9, Cordanum; racemic talinolol
Molecular Formula
C20H33N3O3
Molecular Weight
363.5  g/mol
InChI Key
MXFWWQICDIZSOA-UHFFFAOYSA-N
FDA UNII
3S82268BKG

Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-cyclohexylurea
2.1.2 InChI
InChI=1S/C20H33N3O3/c1-20(2,3)21-13-17(24)14-26-18-11-9-16(10-12-18)23-19(25)22-15-7-5-4-6-8-15/h9-12,15,17,21,24H,4-8,13-14H2,1-3H3,(H2,22,23,25)
2.1.3 InChI Key
MXFWWQICDIZSOA-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O
2.2 Other Identifiers
2.2.1 UNII
3S82268BKG
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane

2. Cordanum

3. Talinolol Acetate

4. Talinolol Benzoate

5. Talinolol Hydrochloride

6. Talinolol Monoacetate

7. Talinolol Monohydrochloride

8. Talinolol Mononitrate

9. Talinolol Monosalicylate

10. Talinolol Nitrate

11. Talinolol Oxalate

12. Talinolol Oxalate (2:1)

13. Talinolol Salicylate

14. Talinolol Sulfate

15. Talinolol Sulfate (2:1)

16. Talinolol Tartrate (2:1), L-(+)-isomer

17. Talinolol Tartrate, L-(+)-isomer

18. Talinolol, (+-)-isomer

2.3.2 Depositor-Supplied Synonyms

1. 57460-41-0

2. Cordanum

3. 1-(4-(3-(tert-butylamino)-2-hydroxypropoxy)phenyl)-3-cyclohexylurea

4. Talinolol [inn]

5. 38649-73-9

6. Cordanum; Racemic Talinolol

7. 1-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-3-cyclohexylurea

8. 1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-cyclohexylurea

9. 3s82268bkg

10. Talinolol (inn)

11. Racemic Talinolol

12. ( Inverted Exclamation Marka)-talinolol

13. Ncgc00164542-01

14. Dsstox_cid_26426

15. Dsstox_rid_81604

16. Dsstox_gsid_46426

17. (+-)-talinolol

18. Talinololum

19. Rac Talinolol

20. Talinololum [inn-latin]

21. Cas-57460-41-0

22. (+/-)-talinolol

23. Unii-3s82268bkg

24. 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane

25. (+-)-n-cyclohexyl-n'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea

26. 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol

27. Talinolol [mi]

28. 1-(3-(3-cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol

29. Talinolol [mart.]

30. Talinolol [who-dd]

31. Schembl78047

32. Chembl152067

33. Gtpl4664

34. Dtxsid6046426

35. Chebi:135533

36. Bcp30483

37. Tox21_112171

38. Bdbm50502344

39. (+-)-1-(p-(3-(tert-butylamino)-2-hydroxypropoxy)phenyl)-3-cyclohexylurea

40. Akos003382147

41. Tox21_112171_1

42. At33613

43. Db11770

44. (+-)-1-(4-(3-(tert-butylamino)-2-hydroxypropoxy)phenyl)-3-cyclohexylharnstoff

45. Urea, N-cyclohexyl-n'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-, (+-)-

46. Ncgc00164542-02

47. Db-072303

48. Ft-0674796

49. D07184

50. Sr-01000945249

51. Q7679533

52. Sr-01000945249-1

53. F1905-6534

54. N-cyclohexyl-n'-[4-(3-tert-butylamino-2-hydroxypropoxy)phenyl]urea

55. 3-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-1-cyclohexylurea

56. N-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-n'-cyclohexylurea

57. N-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-n'-cyclohexylcarbamimidic Acid

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 363.5 g/mol
Molecular Formula C20H33N3O3
XLogP32.6
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count4
Rotatable Bond Count8
Exact Mass363.25219192 g/mol
Monoisotopic Mass363.25219192 g/mol
Topological Polar Surface Area82.6 Ų
Heavy Atom Count26
Formal Charge0
Complexity411
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)


Adrenergic beta-Antagonists

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)


Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


4.2 ATC Code

C - Cardiovascular system

C07 - Beta blocking agents

C07A - Beta blocking agents

C07AB - Beta blocking agents, selective

C07AB13 - Talinolol